Quality-of-Life Outcomes in Female Patients With Ileal Conduit or Orthotopic Neobladder Urinary Diversion: 6-Month Results of a Multicenter Prospective Study.

HRQOL bladder cancer female radical cystectomy urinary diversion

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 15 01 2022
accepted: 14 03 2022
entrez: 6 5 2022
pubmed: 7 5 2022
medline: 7 5 2022
Statut: epublish

Résumé

Radical cystectomy (RC) often affects patients' life as this surgery is a traumatic and invasive event for the patients, with drawbacks on their daily, social, working, and sex life. Such changes in the quality of life (QoL) of patients are commonly studied through retrospective clinical evaluations and rarely with longitudinal studies. To date, studies focusing on functional outcomes, sexual function, and health-related QoL for female patients are lacking. We evaluated 37 patients using EORTC QLQ-C30 (QLQ-30) and Short-Form 36 (SF-36) questionnaires, before and after surgery, at 3 and 6 months of follow-up. The mean values for the emotional functioning in QLQ-C30 as well as the mental health in SF-36 were significantly higher in the ONB group compared to the IC group at 3 months of follow-up. These differences were not significant at 6 months of follow-up. At 6 months of follow-up, the ONB group showed a higher mean score in the physical and role functioning than the IC group. Although there was a statistically significant age difference at baseline of the two groups, none of the results are correlated with age, as demonstrated by Spearman's analysis. The ONB seems to represent the most advantageous solution compared to the IC in terms of QOL at the 6-month follow-up.

Identifiants

pubmed: 35515136
doi: 10.3389/fonc.2022.855546
pmc: PMC9067240
doi:

Types de publication

Journal Article

Langues

eng

Pagination

855546

Informations de copyright

Copyright © 2022 Siracusano, Zaka, Bassi, Gontero, Mearini, Imbimbo, Simonato, Dal Moro, Giannarini, Valotto, Montorsi, Colombo, Porpiglia, Bartoletti, Vella, Minervini, Porcaro, Romantini, Vicentini, Talamini, Ficarra and Lonardi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eur Urol. 2022 May;81(5):515-522
pubmed: 35168844
Surgery. 1992 May;111(5):518-26
pubmed: 1598671
Ann R Coll Surg Engl. 2009 Oct;91(7):565-9
pubmed: 19558757
J Clin Med. 2021 Jul 08;10(14):
pubmed: 34300207
J Urol. 1993 Apr;149(4):758-64; discussion 764-5
pubmed: 8455238
Surg Oncol. 2016 Sep;25(3):281-97
pubmed: 27566035
In Vivo. 2018 Jan-Feb;32(1):139-143
pubmed: 29275311
J Urol. 2000 Jul;164(1):10-3
pubmed: 10840413
Curr Opin Urol. 2019 Sep;29(5):542-547
pubmed: 31313715
Urology. 2021 Jun;152:184-189
pubmed: 33476601
BJU Int. 2014 May;113(5):726-32
pubmed: 24053658
BJU Int. 2004 Aug;94(3):350-4
pubmed: 15291866
SAGE Open Med. 2016 Oct 04;4:2050312116671725
pubmed: 27757230
Eur J Surg Oncol. 2019 Mar;45(3):477-481
pubmed: 30385155
Cancer. 2007 May 1;109(9):1756-62
pubmed: 17366596
Eur J Cancer. 2002 Mar;38 Suppl 4:S125-33
pubmed: 11858978
Eur Urol. 1990;17(2):149-54
pubmed: 2311639
Cancer Nurs. 2014 May-Jun;37(3):170-4
pubmed: 23357883

Auteurs

Salvatore Siracusano (S)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Agustina Zaka (A)

Department of Surgery, Dentistry, Pediatrics and Gynaecology, University of Verona, Verona, Italy.

Pierfrancesco Bassi (P)

Department of Medicine and Surgery, Rome Catholic University, Rome, Italy.

Paolo Gontero (P)

Department of Surgical Science, Turin University, Turin, Italy.

Ettore Mearini (E)

Department of Medicine and Surgery, Perugia University, Perugia, Italy.

Ciro Imbimbo (C)

Department of Urology, Federico II Naples University, Naples, Italy.

Alchiede Simonato (A)

Department of Urology, Palermo University, Palermo, Italy.

Fabrizio Dal Moro (F)

Department of Urology, Padova University, Padova, Italy.

Gianluca Giannarini (G)

Department of Urology, Udine Hospital, Udine, Italy.

Claudio Valotto (C)

Department of Urology, Udine Hospital, Udine, Italy.

Francesco Montorsi (F)

Department of Urology, San Raffaele Hospital, Vita e Salute University, Milan, Italy.

Renzo Colombo (R)

Department of Urology, San Raffaele Hospital, Vita e Salute University, Milan, Italy.

Francesco Porpiglia (F)

Department of Urology, Orbassano Hospital, Turin University, Turin, Italy.

Riccardo Bartoletti (R)

Department of Urology, Pisa University, Pisa, Italy.

Marco Vella (M)

Department of Urology, Palermo University, Palermo, Italy.

Andrea Minervini (A)

Department of Urology, Florence University, Florence, Italy.

Antonio Benito Porcaro (AB)

School of Medicine and Surgery, Verona University, Verona, Italy.

Federico Romantini (F)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Carlo Vicentini (C)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Renato Talamini (R)

Department of Epidemiology, Aviano Oncology Center, Aviano, Italy.

Vincenzo Ficarra (V)

Department of Urology, University of Messina, Messina, Italy.

Cristina Lonardi (C)

Department of Human Sciences, Verona University, Verona, Italy.

Classifications MeSH